🇺🇸 FDA
Patent

US 8758723

Compositions and methods for cellular imaging and therapy

granted A61KA61K47/547A61K51/0474

Quick answer

US patent 8758723 (Compositions and methods for cellular imaging and therapy) held by The Board of Regents of the University of Texas System expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
35
CPC classes
A61K, A61K47/547, A61K51/0474, A61K51/0491, A61P